Human Serum Albumin — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

6 Recruiting

2 Completed trials

8 Sponsors

14 Countries

Phase III

Phase II

Phase IV

Phase I (FiH)

Phase III: 4 Phase II: 3 Phase IV: 2 Phase I (FiH): 1

Indications tested

Ovarian epithelial cancer 1

Sponsors using this IMP

European Foundation For The Study Of Chronic Liver Failure 3 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 2 Odense University Hospital 2 Fundacio Parc Tauli 1 Hopital Fondation Adolphe De Rothschild 1 IIS La Fe 1 Immatics Biotechnologies GmbH 1 Instituto Grifols S.A. 1

All trials

10 total

An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised

2022-501006-34-00 Phase III 6 countries European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre… Pending

2023-509713-37-00 Phase II 1 country Hopital Fondation Adolphe De Rothschild
LIVER AKI: A trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with … Recruiting

2025-521457-16-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Impact of Albumin on Renal function in critically ill patients with Septic Shock and a high risk of Acute Kidney Injury. A Randomized Contro… Recruiting

2024-518475-58-00 Phase IV 1 country Fundacio Parc Tauli
VALIDATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY-STAGE OVARIAN CANCER (SENTOV II) Recruiting

2024-520189-67-00 Phase III 1 country IIS La Fe
A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome (COMBAT tria… Recruiting

2023-507073-18-00 Phase II 4 countries European Foundation For The Study Of Chronic Liver Failure
A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific T Cell-Engag… Recruiting

2022-503133-54-00 Phase I (FiH) 2 countries Immatics Biotechnologies GmbH
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Recruiting

2022-501006-34-01 Phase III 7 countries European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
Sentinel node detection with 99Tc albumin nanocolloid and indocianine green (ICG) in patients with epithelial ovarian cancer in early stages… Ended

2023-505667-37-00 Phase II 1 country Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques Augus…
Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality Ended

2022-502187-20-00 Phase III 11 countries Instituto Grifols S.A.

Showing 1–10 of 10 trials

← All drugs A–Z